文献速递血液净化与透析肾移植

美国终末期肾病患者产科分娩趋势与结局:2002-2015

Obstetric Deliveries in US Women With ESKD: 2002-2015.
PubMed 文献 · Am J Kidney Dis · 2019-11-27

该回顾性队列研究纳入2002至2015年美国肾脏数据系统中18至44岁女性终末期肾病患者,分析分娩率趋势及结局。结果显示血液透析和肾移植患者的分娩率均显著上升,腹膜透析患者较低且无显著增加。肾移植患者早产风险较低但剖宫产风险较高。

要点

  • 血液透析和肾移植患者分娩率分别从2.1升至3.6和3.1升至4.6每1000患者年。
  • 肾移植患者较血液透析患者早产风险更低(OR 0.92),但剖宫产风险更高(OR 1.18)。
  • 2012至2015年,75%血液透析孕妇在分娩前30天每周接受4次或更少门诊透析。

核心结论

  • 2002至2015年间,接受血液透析或肾移植的育龄终末期肾病女性分娩率上升。
  • 有功能肾移植的女性早产可能性较低,但剖宫产可能性较高。
  • 2012至2015年间,终末期肾病孕妇接受门诊强化血液透析的处方不常见。

研究设计与样本

  • 回顾性队列研究,纳入2002至2015年美国肾脏数据系统中18至44岁女性终末期肾病患者。

主要发现

  • 血液透析患者分娩率从2.1升至3.6每1000患者年(P<0.001)。
  • 肾移植患者分娩率从3.1升至4.6每1000患者年(P<0.001)。
  • 腹膜透析患者分娩率较低且无显著增加(P=0.9)。
  • 肾移植患者较血液透析患者早产风险更低(OR 0.92;95% CI 0.84-1.00)。
  • 肾移植患者较血液透析患者剖宫产风险更高(OR 1.18;95% CI 1.06-1.31)。

关键数值与推荐

  • 2012至2015年分娩的血液透析患者中,75%在分娩前30天每周处方4次或更少门诊血液透析。
  • 2012至2015年分娩的血液透析患者中,25%在分娩前30天每周处方5次或以上门诊血液透析。

临床怎么用

  • 终末期肾病育龄女性妊娠管理需关注透析模式与移植状态对早产和剖宫产风险的影响。
  • 血液透析孕妇中门诊强化透析处方比例较低,提示临床实践与指南推荐可能存在差距。

局限性

  • 结局和合并症通过行政索赔数据确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Women with end-stage kidney disease (ESKD) have decreased fertility and are at increased risk for pregnancy complications. This study examined secular trends and outcomes of obstetric deliveries in a US cohort of women with ESKD. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Women aged 18 to 44 years with ESKD and registered in the US Renal Data System from 2002 to 2015. EXPOSURE: ESKD modality (hemodialysis [HD], peritoneal dialysis, transplantation). OUTCOMES: Infant delivery, preterm delivery, cesarean delivery. ANALYTICAL APPROACH: Unadjusted delivery rates were expressed as number of delivering women per 1,000 patient-years among women aged 18 to 44 years within each year during the study period, stratified by ESKD modality. Logistic regression models were used to evaluate associations of delivery, preterm delivery, and cesarean delivery with patient characteristics. RESULTS: The delivery rate in women undergoing HD and women with a kidney transplant increased from 2.1 to 3.6 and 3.1 to 4.6 per 1,000 patient-years, respectively (P<0.001 for each). The delivery rate in patients undergoing peritoneal dialysis was lower and did not increase significantly (P=0.9). Women with a transplant were less likely to deliver preterm compared with women undergoing HD (OR, 0.92; 95% CI, 0.84-1.00), though more likely have a cesarean delivery (OR, 1.18; 95% CI, 1.06-1.31). For deliveries occurring in the 2012 to 2015 period, 75% of women treated with HD were prescribed 4 or fewer outpatient HD treatments per week and 25% were prescribed 5-plus treatments per week in the 30 days before delivery. LIMITATIONS: Ascertainment of outcomes and comorbid conditions using administrative claims data. CONCLUSIONS: The delivery rate in women of reproductive age with ESKD increased from 2002 to 2015 among those treated with transplantation or HD. Women with a functioning transplant were less likely to deliver preterm, but more likely to have a cesarean delivery. Prescriptions for outpatient intensified HD for pregnant women with ESKD were infrequent in 2012 to 2015.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Oliverio AL, Bragg-Gresham JL, Admon LK, et al. Obstetric Deliveries in US Women With ESKD: 2002-2015. Am J Kidney Dis. 2019. PMID: 31785826. doi:10.1053/j.ajkd.2019.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。